DJIA 17,810.06 91.06 0.51%
NASDAQ 4,712.97 11.10 0.24%
S&P 500 2,063.50 10.75 0.52%
market minute promo

ImmunoGen (NASDAQ: IMGN)

9.84 0.16 (1.65%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

IMGN $9.84 1.65%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $9.83
Previous Close $9.68
Daily Range $9.70 - $10.02
52-Week Range $7.70 - $17.80
Market Cap $845.6M
P/E Ratio -10.08
Dividend (Yield) $0.00 (0.0%)
Volume 702,495
Average Daily Volume 1,657,596
Current FY EPS -$0.70





ImmunoGen (IMGN) Description

ImmunoGen develops cancer therapeutics through its tumor-activated, prodrug technology, which targets antibodies with cancer-killing drugs. Website:

News & Commentary Rss Feed

Why ImmunoGen, Inc. Stock Plunged 13% in October

ImmunoGen is among biotech's worst stocks in October after the company reports weaker-than-expected third quarter results. Find out if a rebound is in the cards.

ImmunoGen: Analysis Of Earnings Miss

ImmunoGen, Inc. Pushes Forward

With just $4.2 million in royalties from Roche's Kadcyla, investors need to be focused on ImmunoGen's internal pipeline.

ImmunoGen's (IMGN) CEO Daniel Junius on Q1 2015 Results - Earnings Call Transcript

ImmunoGen (IMGN) Q3 2014 Results - Earnings Call Webcast

ImmunoGen (IMGN) in Focus: Stock Rallies 14% - Tale of the Tape

ImmunoGen (IMGN) in Focus: Stock Rallies 14% - Tale of the Tape

Immunogen (IMGN) Highlighted As Today's Perilous Reversal Stock

Trade-Ideas: Immunogen (IMGN) Is Today's Strong On High Relative Volume Stock

Today's Weak On High Volume Stock: Immunogen (IMGN)

3 Value Stocks Near 52-Week Lows Worth Buying

These value stocks may be hitting a new 52-week low, but they may not be there for long!

See More IMGN News...

IMGN's Top Competitors

IMGN $9.84 (1.65%)
Current stock: IMGN
GILD $100.58 (-0.01%)
Current stock: GILD
CELG $108.20 (0.79%)
Current stock: CELG
AMGN $162.81 (0.08%)
Current stock: AMGN